Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Novavax Omicron XBB.1.5 Booster in Adolescents
NCT05973006Phase 3Completed
- Sponsor
- Novavax
- Start
- Aug 2023
- Primary completion
- Apr 2024
- Modality
- Nanoparticles, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of Nuvaxovid XBB.1.5 in coronavirus disease 2019 (COVID-19), sponsored by Novavax. Started Aug 2023; status: completed.
02
Drugs
Nuvaxovid XBB.1.5
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT05973006.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05973006.